Thank you for your feedback
Thank you for your detailed feedback. We appreciate your thorough review and would like to address each of your comments below.
---
>Were the results on the other 4 datasets not positive findings?
The full test sets for Fever, Feverous, and Vitaminc are indeed quite large, with approximately 10,000 instances each for Fever and Feverous, and over 50,000 for Vitaminc. Due to time constraints during the rebuttal period, we initially prioritized reporting performance within the QA domain. However, we have since conducted additional experiments, and we now present the results on all seven datasets:
Model | | Bam | 2wiki | hotpotqa | fever | feverous | vitaminc | svamp | Avg.|
| ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |---- |---- |
|LLaMa2-7b |CoT |29.6| 23.8| 20.7| 38.6| 51.2| 50.5| 37.7|36.0|
| |TS-SFT| 30.4| 24.1| 22.7| 40.3| 53.0| 53.0 |43.1|38.1|
||CPO| **32.0**| **26.1**| **24.0**| **45.1**| **56.2**|**55.2**| **46.0**|**40.7**|
|LLaMa2-13b| CoT| 48.0| 28.4| 27.0| 47.4| 49.9| 50.8| 40.3|41.7|
| |TS-SFT| 50.8| 29.0| 28.1| 48.0| 48.8| 53.8| 44.6|43.3|
| |CPO| **52.0**| **30.3**| **28.5**| **49.7**| **50.7**| **59.6**| **50.0**|**45.8**|
Mistral-7b| CoT| 41.6|27.5|24.8|53.6|54.0|53.8 |65.3|45.8|
||TS-SFT| 41.6|30.3|25.1 |**56.0**|55.0|57.1| 59.0|46.3|
| |CPO| **45.6**|**31.3**|**25.9**|55.7|**60.1**|**60.0**| **69.3**|**49.7**|
Our findings indicate that the relative improvement of CPO over the baselines is consistent with our previously reported results. We will clarify it and incorporate these expanded evaluations into the revised paper.
---
> Why is Table B missing the other baselines?
Due to time constraints during the rebuttal period, we prioritized demonstrating CPO's potential to improve performance on new tasks, including GSM8k, rather than emphasizing its superiority over other methods. However, as per your suggestion, we have now included the experimental results for ToT and TS-SFT on GSM8k. Since some settings need to be clarified before presenting the results, please refer to our response to the following comments for detailed results and conclusions.
---
>Moreover, others have found (e.g. in the Gemma report that Llama-2-7B matches your 14.6% performance on GSM using just few-shot prompting. This suggests that CPO is not providing any benefits.
The performance of 8-shot prompting on GSM8k using LLaMA-2-7B, as reported in the Gemma report, is comparable to our CPO using 4-shot prompting (see lines 169-170). We extended our evaluation to 8-shot prompting here, consistent with the Gemma report settings:
||ToT|CoT|TS-SFT|CPO|
| ---- | ---- | ---- | ---- |---- |
|GSM8k|16.2|14.2|14.8|15.3|
We found that our COT approach achieves similar performance to that reported in the Gemma report, with CPO further improving the results to 15.3%.
---
> Are the TS-SFT and ToT worse than CPO (raising questions about statistical significance), or are they stronger than CPO?
As shown in the table provided in our previous response, CPO outperforms TS-SFT, as confirmed by a bootstrap significance test, which yielded a p-value of 0.0011 (p < 0.05), indicating a statistically significant difference. However, ToT is superior to CPO. This result is expected, as ToT serves as the teacher method for our CPO method, guiding its improvements.
---
>Which datasets are the Figure C plots computed over?
For $\\textrm{\\color{blue}Figure C (a)}$ and $\\textrm{\\color{blue}(b)}$, as labeled on the x-axis, the results are reported for the Bamboogle and Fever datasets, respectively. For $\\textrm{\\color{blue}Figure C (c)}$, we present the results on the Bamboogle dataset. We will ensure clarity when we include these figures in the final revision. The reason for reporting results on only one dataset is the computational cost associated with using ToT for dataset construction (e.g., over 1740 A100 GPU hours for LLaMA 2-7B on the Fever dataset). However, we are continuing to conduct this ablation and will include the results in the revised version.
---
We hope these efforts address your concerns. If you have any further feedback, we will do our best to respond.